Antipsychotic Trials in Schizophrenia: The CATIE Project (Cambridge Medicine (Hardcover))
ISBN-13:
9780521895330
ISBN-10:
0521895332
Edition:
1
Author:
Jeffrey A. Lieberman, T. Scott Stroup
Publication date:
2010
Publisher:
Cambridge University Press
Format:
Hardcover
330 pages
Category:
Schizophrenia
,
Mental Health
,
Psychopharmacology
,
Psychology & Counseling
,
Pathologies
,
Psychology
,
Psychopharmacology
FREE US shipping
Book details
ISBN-13:
9780521895330
ISBN-10:
0521895332
Edition:
1
Author:
Jeffrey A. Lieberman, T. Scott Stroup
Publication date:
2010
Publisher:
Cambridge University Press
Format:
Hardcover
330 pages
Category:
Schizophrenia
,
Mental Health
,
Psychopharmacology
,
Psychology & Counseling
,
Pathologies
,
Psychology
,
Psychopharmacology
Summary
Antipsychotic Trials in Schizophrenia: The CATIE Project (Cambridge Medicine (Hardcover)) (ISBN-13: 9780521895330 and ISBN-10: 0521895332), written by authors
Jeffrey A. Lieberman, T. Scott Stroup, was published by Cambridge University Press in 2010.
With an overall rating of 3.9 stars, it's a notable title among other
Schizophrenia
(Mental Health, Psychopharmacology, Psychology & Counseling, Pathologies, Psychology, Psychopharmacology) books. You can easily purchase or rent Antipsychotic Trials in Schizophrenia: The CATIE Project (Cambridge Medicine (Hardcover)) (Hardcover) from BooksRun,
along with many other new and used
Schizophrenia
books
and textbooks.
And, if you're looking to sell your copy, our current buyback offer is $0.02.
Description
Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach $20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the comparative effectiveness of medications. CATIE was the largest, longest and most comprehensive study of schizophrenia to date. Conducted under rigorous double-blind conditions, Antipsychotic Trials in Schizophrenia presents the definitive archival results of this landmark study. The core of the book consists of chapters focused on specific outcomes that set the CATIE findings in a wider context. Also included are chapters on the design, statistical analyses and implications for researchers, clinicians and policy makers. Psychiatrists, psychiatric researchers, mental health policy makers and those working in pharmaceutical companies will all find this to be essential reading.
We would LOVE it if you could help us and other readers by reviewing the book
Book review
Congratulations! We have received your book review.
{user}
{createdAt}
by {truncated_author}